학술논문
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)
Document Type
Review Article
Author
Source
In Clinical Microbiology and Infection June 2018 24 Supplement 2:S83-S94
Subject
Language
ISSN
1198-743X